Skip to main content
CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. logo

CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. — Investor Relations & Filings

Ticker · 000661 ISIN · CNE0000007J8 LEI · 300300X04OTKZG18WD66 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,288 across all filing types
Latest filing 2021-03-11 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 000661

About CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD.

https://ccht.jl.cn

CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. is a diversified enterprise primarily focused on the research, development, production, and distribution of biopharmaceuticals and healthcare products. The company operates through several key subsidiaries, most notably GeneScience Pharmaceuticals, which specializes in recombinant human growth hormones and pediatric endocrinology treatments. Its product portfolio includes biological drugs, vaccines, and traditional Chinese medicines, targeting therapeutic areas such as growth disorders, infectious diseases, and oncology. The group emphasizes technological innovation and maintains a significant presence in the domestic market while expanding its international footprint. In addition to its core life sciences business, the company maintains interests in real estate development and infrastructure management.

Recent filings

Filing Released Lang Actions
年度关联方资金占用专项审计报告
Audit Report / Information Classification · 95% confidence The document is titled as an audit report on the situation of funds occupied by controlling shareholders and other related parties for the year 2020. It is issued by a certified public accounting firm and includes an audit opinion, responsibilities of management and auditors, and a detailed summary table of the fund occupation. The document length is 3140 characters, which is relatively short but contains substantive audit content and financial data related to the specific issue of related party fund occupation. It is not a full annual report, nor a simple announcement or certification. It fits the definition of an Audit Report / Information (AR) as it is a standalone audit report focusing on a specific financial issue, with audit procedures and opinion provided. Therefore, the classification is AR with high confidence. FY 2020
2021-03-11 Chinese
2020年度董事会工作报告
Board/Management Information Classification · 95% confidence The document is titled '2020 年度董事会工作报告' which translates to '2020 Annual Board of Directors Work Report'. It details the board's activities, company performance, governance, and future plans for the year 2020. It includes comprehensive operational and financial performance data, descriptions of board meetings, committee activities, and governance practices. The content is consistent with a Management Report or Board/Management Information report rather than a full Annual Report (10-K) or Audit Report. It is not a short announcement or certification but a substantive report on board activities and company management for the year. Therefore, the document fits best under the category 'Board/Management Information' (MANG).
2021-03-11 Chinese
年度募集资金使用情况专项说明
Capital/Financing Update Classification · 95% confidence The document is a detailed report on the actual deposit and usage of raised funds by 长春高新技术产业（集团）股份有限公司 for the fiscal year 2020. It includes specifics on fundraising amounts, usage by year, management of funds, changes in investment projects, and audit verification by an accounting firm. The document references regulatory approvals from the China Securities Regulatory Commission and includes detailed tables on fund usage and changes. The content focuses exclusively on the management and use of capital raised through share issuance and non-public offerings, with no indication of it being a general annual report, earnings release, or other types of filings. This matches the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes. The document length is substantial (over 12,000 characters) and contains substantive financial data and analysis related to fundraising and capital usage, not merely an announcement or certification. Therefore, the correct classification is CAP.
2021-03-11 Chinese
关于控股子公司鼻喷流感减毒活疫苗（液体剂型）获得药物临床试验批准通知书的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from a company about its subsidiary receiving approval for clinical trials of a vaccine. It is a regulatory announcement related to drug clinical trial approval from a government agency. There is no financial data, no mention of financial results, no report attached or referenced, and no indication of management or board changes. The document is short (613 characters) and serves as a formal notification to investors about a regulatory milestone. This fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2021-03-03 Chinese
2021年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled as a resolution announcement from the 2021 first extraordinary shareholders' meeting of Changchun High-tech Industry (Group) Co., Ltd. It details the meeting date, voting methods, attendance, voting results, and legal opinions confirming the validity of the meeting and resolutions. There is no financial data or detailed report content, only the announcement of the meeting's resolutions and voting outcomes. The document length is short (1846 characters), and it serves as an official announcement of voting results from a shareholders' meeting. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2021-02-17 Chinese
北京大成（长春）律师事务所关于长春高新2021年第一次临时股东大会的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the legality of the procedures and results of a company's 2021 first extraordinary general meeting (临时股东大会). It details the convening, attendance, voting procedures, and results of the shareholders' meeting. It does not contain financial statements or financial performance data, nor is it a report or announcement of financial results. It is not a proxy solicitation or voting results announcement per se, but a legal opinion on the meeting's compliance with laws and regulations. This type of document is best classified under Regulatory Filings (RNS) as it is a compliance/legal opinion related to corporate governance and shareholder meetings, but does not fit other more specific categories.
2021-02-17 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.